#NationalDiabetesWeek #LivingOutLoud #StrongerTogether #Type2diabetes #Codesign #FoodLiteracy #DiabetesResearch (Illustration created using ChatGPT) To view or add a comment, sign in New umbrella review with meta-analysis in The Lancet Digital Health: Smartphone apps improve outcomes related to cardiovascular disease, glucose control, mental outcomes, physical activity and quality of life
How about supplements
An 125I-labeled N6-substituted azido analog of NAD+ for the photoaffinity labeling of NAD(+)-linked enzymes
Ozyazgan S, Kutluata N, Afsar S, Ozdas SB, Akkan AG: Effect of glucagon-like peptide-1(736) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats
Reported fat loss in the extract group was roughly six times that of placebo [4]
Ozempic and Wegovy have joined a list of medications subject to price negotiations for Medicare Part D, which could put more pressure on revenues